OCULAR GENETICS IS CHANGING PAEDIATRIC OPHTHALMOLOGY

Arthur Cummings
Published: Friday, September 4, 2015
More support for ocular genetics training programmes, and more collaboration with ophthalmologists, are needed to realise the tremendous promise of genetic research to improve ophthalmic care, Alex V Levin MD, Chief of Paediatric Ophthalmology and Ocular Genetics at Wills Eye Hospital, Philadelphia, USA, told the 3rd World Congress of Paediatric Ophthalmology and Strabismus in Barcelona.
Dr Levin noted that the first examples of many categories of genetic disorders have ocular manifestations. These include piebaldism, the first autosomal dominant disorder described, and red-green colour blindness, the first X-linked recessive disorder other than haemophilia.
“Eye genetics rules. We are the first in so many areas. Why?” Dr Levin asked.
It may be that genetic variations are more easily observed in the transparent tissues of the eye than in other organs. For example, lyonization, in which heterozygous X-linked genes are randomly expressed in half the cells of females, can conceal a recessive X-linked disease such as ocular albinism in most body parts. But it appears as a mud-splattered pattern on the retina, where expression of the recessive gene is skewed, Dr Levin said.
Genetic research is leading to promising treatments for previously incurable disease, Dr Levin said. “When a 12-year-old comes in with retinitis pigmentosa we no longer have to say ‘sorry’, we can say it will be curable within your lifetime.”
But genetic diagnosis and counselling requires tremendous expertise and exhaustive effort tracing family histories and genetic tests – resources commonly available only in academic settings. More training programmes are needed to expand the supply of ocular geneticists, which currently stands at about 70 worldwide, Dr Levin said.
Latest Articles
Organising for Success
Professional and personal goals drive practice ownership and operational choices.
Update on Astigmatism Analysis
Is Frugal Innovation Possible in Ophthalmology?
Improving access through financially and environmentally sustainable innovation.
iNovation Innovators Den Boosts Eye Care Pioneers
New ideas and industry, colleague, and funding contacts among the benefits.
José Güell: Trends in Cornea Treatment
Endothelial damage, cellular treatments, human tissue, and infections are key concerns on the horizon.
Making IOLs a More Personal Choice
Surgeons may prefer some IOLs for their patients, but what about for themselves?
Need to Know: Higher-Order Aberrations and Polynomials
This first instalment in a tutorial series will discuss more on the measurement and clinical implications of HOAs.
Never Go In Blind
Novel ophthalmic block simulator promises higher rates of confidence and competence in trainees.
Simulators Benefit Surgeons and Patients
Helping young surgeons build confidence and expertise.